Puma Biotechnology (PBYI) PT Raised to $9 at Goldman Sachs
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Price: $9.17 +1.33%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi raised the price target on Puma Biotechnology (NASDAQ: PBYI) to $9.00 (from $8.00) while maintaining a Sell rating.
You May Also Be Interested In
- The Lovesac Co. (LOVE) PT Lowered to $20 at Canaccord
- Yunda Holding Co Ltd (002120:CH) PT Lowered to RMB8 at CLSA
- Nomura/Instinet Starts Hanwha Ocean Co Ltd (042660:KS) at Reduce
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
